U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
By I. Edwards HealthDay Reporter
TUESDAY, May 13, 2025 — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.
The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued the warning late last week.
The concern focuses on the Valneva vaccine, known as Ixchiq, The Associated Press reported. Valneva is a specialty vaccine developer based in France.
Chikungunya is a tropical illness spread by mosquito bites. It causes fever and painful joints. About 100 to 200 U.S. travelers get the illness each year.
The government previously recommended the vaccine for adults traveling to areas where chikungunya may be common, including countries in Central and South America, Asia, India and Africa. The vaccine uses a weakened version of the virus.
The AP reported that a panel of CDC advisers recently learned of six seniors who developed serious heart or brain symptoms within a week of vaccination. Most had other health problems.
Officials also received reports of more than 10 similar cases in other countries.
European regulators are also investigating, AP reported.
A CDC advisory panel has now urged caution for adults aged 65 and older considering the Ixchiq vaccine.
They also recommended a second vaccine, Vimkunya by Bavarian Nordic, for people 12 and older traveling to areas with chikungunya outbreaks.
CDC officials have not yet made a final decision on the new recommendations.
Sources
- The Associated Press, May 12, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
FDA Fully Approves Moderna’s COVID Vaccine for Some Young Kids
FRIDAY, July 11, 2025 — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical...
American Academy of Pediatrics Sues HHS Over Vaccine Policy
TUESDAY, July 8, 2025 -- The American Academy of Pediatrics is suing the U.S. Department of Health and Human Services because of its recent decisions regarding vaccines for...
U.S. Measles Cases Hit Highest Level Since Disease Was Eliminated in 2000
TUESDAY, July 8, 2025 — Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year. That number...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.